The G-BA Innovation Committee recommends transfer to standard care for another three projects in Germany

On May 15, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for another three completed projects. The projects relate to controlling drug prescriptions in outpatient settings, evaluating the effectiveness of outpatient extensive stuttering therapy in primary school children, and the efficacy of cross-sectoral care models in psychiatry.

The project “WirtMed - The prescription of drugs: testing and controlling of economic efficiency and quality” examined different aspects of checking and controlling drug prescriptions in outpatient settings. The project results can contribute to the further development of testing procedures and the control of drug prescriptions.

The “PMS KIDS - Prospective, multicentre study on the effectiveness of outpatient stuttering therapy according to the stuttering modification approach KIDS” project evaluated the effectiveness of outpatient extensive stuttering therapy according to the stuttering modification method ("Children are allowed to stutter") in elementary school age. The study aimed to close the evidence gap identified in the S3 guideline "Oral fluency disturbances" on the effectiveness of the treatment of stuttering in primary school children. Objectively measured improvements in the severity of stuttering were demonstrated in a before-after comparison for the measurement points of 6 and 12 months after the start of therapy.

The ”PsychCare - Effectiveness of cross-sectoral care models in psychiatry” project examined the benefits, costs, and efficiency of existing psychiatric model projects compared to standard care. The project results indicate that model projects on psychiatric care can be further developed.

The detailed results of the projects are now being forwarded to the relevant organizations and institutions in the healthcare sector. In this regard, the respective stakeholders are requested to review the results and consider them within their area of responsibility as much as possible, specifically concerning the quality assurance aspect.

The full details in German can be found here, here (the decision and the results of the WirtMed project), here (the decision and the results of the PMS KIDS project), and here (the decision and the results of the PsychCare project).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.